News
Dick Harpootlian at CrimeCon 2023
Dick Harpootlian at CrimeCon 2023 talks about the State v. South Carolina v. Richard Alexander Murdaugh trial.
Thousands of true-crime enthusiasts converged in Orlando, Florida the end of September and Dick Harpootlian was there with a CrimeCon exclusive and new developments in the Murdaugh case….
Alex Murdaugh press release on newly discovered evidence
Today, Jim Griffin and I filed a petition based on newly discovered evidence with the SC Court of Appeals to stay Alex Murdaugh’s appeal while a hearing is held on a motion for a new trial.…
Read MoreLISTEN to Dick Harpootlian on NITA podcast
LISTEN to Dick Harpootlian on NITA podcast
May the Record Reflect, Episode 24
Dispute over whistleblower’s bounty featured in Bloomberg Law report
A December 26, 2017 report by Bloomberg Law cited a district court’s decision to award a False Claims Act (FCA) whistleblower 28 percent of the recovery over the Department of Justice’s (DOJ’s) argument she should receive the statutory minimum of 25 percent….
Read MoreUnderutilized Tool – Excel
As technology transforms the practice of law, it’s vital for paralegals and litigation support professionals to continue to develop new skills. Excel is an underutilized tool for managing litigation. Excel increases productivity & efficiency in a law firm.
Recently, Tim Thames led an Excel training course….
Whistleblower settlement with drug maker featured in SC Lawyers Weekly
The lede in the August 7, 2017 edition of South Carolina Lawyers Weekly feature news of a recent $280 million federal False Claims Act (FCA) settlement with Celgene Corp. involving Dick Harpootlian and Chris Kenney. …
Read MoreCelgene settlement reported by Bloomberg, Law360
A $280 million federal False Claims Act (FCA) settlement between the United States government and pharmaceutical giant Celgene Corporation is being reported this morning by Bloomberg News and Law360. The settlement was reached after the United States declined to “intervene”…
Read MoreBio Pharma Giant — Celgene — Settles Case Alleging Marketing Violations For $280 Million
LOS ANGELES, July 25, 2017 /PRNewswire-USNewswire/ — On the eve of trial, Bio Pharma giant, Celgene Corporation, has agreed to pay $280 million to resolve allegations it sold and promoted its blockbuster drugs,…
Read MoreJury Practice in Post-Truth America
An article by Dick Harpootlian and Chris Kenney has been published in a special Presidential Inauguration Issue of the Emory Corporate Governance and Accountability Review. The article, “Jury Practice in Post-Truth America: A Cautionary Note” (4 Emory Corp….
Read MoreMethadone clinic sued over crash that killed four
A September 10, 2016 article by The State Newspaper reports on a federal lawsuit against a West Columbia clinic that dispensed methadone to a patient whose vehicle crossed into oncoming traffic and struck another vehicle, killing 16-year old Stephen Cooper Gunnells,…
Read MoreWhistleblower lawsuit against hospital settled for $17 million
A July 23, 2016 article by The State Newspaper’s John Monk reports a federal whistleblower lawsuit against Lexington Medical Center (LMC) has been settled for $17 million.
The case, brought by former LMC neurologist David Hammett, alleged the hospital illegally compensated employee physicians like Dr….